I-026

Interference Mix 4 (For Qualitative Use Only)

5-100 μg/mL each component in methanol, Cerilliant^®

• 别名: Qualitative Interference Mixture
• UNSPSC代码: 41116107
• NACRES: NA.24

属性

• 等级: analytical standard
• 质量水平: 100
• 表单: liquid
• 组成: Alprazolam, 100 μg/mL ; Cimetidine, 100 μg/mL ; Citalopram hydrobromide, 100 μg/mL (as free base); Clonazepam, 100 μg/mL ; Clopidogrel bisulfate, 100 μg/mL (as free base); Dextromethorphan, 50 μg/mL ; Fluconazole, 100 μg/mL ; Hydrochlorothiazide, 100 μg/mL ; Lamotrigine, 100 μg/mL ; Methylphenidate hydrochloride, 100 μg/mL (as free base); Omeprazole, 100 μg/mL ; L-Thyroxine, 5 μg/mL
• 包装: ampule of 1 mL
• 制造商/商品名称: Cerilliant^®
• drug control: psicótropo (Spain); Decreto Lei 15/93: Tabela IV/IIB (Portugal)
• 浓度: 5-100 μg/mL each component in methanol
• 技术: gas chromatography (GC): suitable; liquid chromatography (LC): suitable
• 应用: forensics and toxicology
• 包装形式: single component solution
• 储存温度: −20°C

说明

一般描述

A multi-component solution standard of routinely monitored over-the-counter (OTC) and prescription drugs alprazolam; cimetidine; citalopram HBr; clonazepam; clopidogrel bisulfate; dextromethorphan; fluconazole; hydrochlorothiazide; lamotrigine; L-thyroxine; methylphenidate HCl; and omeprazole. This standard is for qualitative use only in the evaluation of interferences between the mix components and target analytes of interest in a testing laboratory′s analytical methods.

法律信息

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

安全信息

• 象形图: GHS02,GHS06,GHS08
• 警示用语：: Danger
• 危险声明: H225,H301 + H311 + H331,H370
• 预防措施声明: P210 - P233 - P280 - P301 + P310 - P303 + P361 + P353 - P304 + P340 + P311
• 危险分类: Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1
• 靶器官: Eyes,Central nervous system
• 储存分类代码: 3 - Flammable liquids
• WGK: WGK 2
• 闪点(°F): 49.5 °F - closed cup
• 闪点(°C): 9.7 °C - closed cup